Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00050050 · ClinicalTrials.gov registry record · Phase 1
Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity Disorder
A Phase 1 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT00050050: Completed Phase 1 study, sponsored by Massachusetts General Hospital.
NCT00050050 is a Phase 1 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00050050, a Phase 1 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study will determine the effectiveness of cognitive behavioral therapy (CBT) in treating the symptoms of attention deficit hyperactivity disorder (ADHD) in adults who have not responded to drug treatment. Study hypothesis: CBT is an effective treatment for adult ADHD.
Interventions
- BEHAVIORAL Cognitive behavioral therapy
- DRUG Drug therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2001-09 |
| Est. Completion | 2003-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00050050
The ClinicalTrials.gov registry entry for NCT00050050 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cognitive behavioral therapy is the first listed.
NCT00050050 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00050050 about?
NCT00050050 is a clinical study titled "Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity Disorder". This study will determine the effectiveness of cognitive behavioral therapy (CBT) in treating the symptoms of attention deficit hyperactivity disorder (ADHD) in adults who have not responded to drug treatment. Study hypothesis: CBT is an effective treatment for adult ADHD.
What is the current status of trial NCT00050050?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2001-09. Estimated completion is 2003-08.
What interventions are being tested in trial NCT00050050?
The interventions under investigation include: Cognitive behavioral therapy (BEHAVIORAL), Drug therapy (DRUG).
Who is sponsoring clinical trial NCT00050050?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.